Home » Oral Drug Stalls Clinically Definite MS
Oral Drug Stalls Clinically Definite MS
A study conducted in Copenhagen showed that Aubagio reduced the risk of definitive symptoms of disease in patients who had already shown initial symptoms of multiple sclerosis (MS).
Medpage Today
Medpage Today
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May